Results 241 to 250 of about 32,756 (253)

Glucagon-Like Peptide 1 Receptor Agonist

openaire   +1 more source

Glucagon-like peptide-1 receptor agonists and aspiration risk

BMJ
Daniel I, McIsaac, Gregory L, Bryson
openaire   +2 more sources

Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes

Diabetes Care
Richeek Pradhan, Hui Yin, Giada Sebastiani   +2 more
exaly  

Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes

Ophthalmology
Jawad Muayad, Asad Loya, Zain S Hussain   +2 more
exaly  

Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications

Therapeutic Advances in Endocrinology and Metabolism
Saleh Hadi Alharbi
exaly  

Obesity, diabetes and glucagon-like peptide-1 receptor agonists

Archives of Disease in Childhood
openaire   +2 more sources

Impact of Glucagon-Like Peptide-1 Receptor Agonists on Postoperative Outcomes in Arthroplasty: A Systematic Review

Journal of Arthroplasty
Brent A Ponce
exaly  

Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease

Frontiers in Pharmacology
Cheng Xinyi, Hu Pengfei
exaly  

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes

Journal of the American Heart Association
Loukia Pliouta, Eleni Michalopoulou, Ignatios Ikonomidis   +2 more
exaly  

Weighing in on glucagon-like peptide-1 receptor agonists in dermatology

Journal of the American Academy of Dermatology
openaire   +2 more sources